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Abstract
Purpose This study aimed to empirically compare the measurement properties of self-reported and proxy-reported (in 
cases of severe cognitive impairment) generic (EQ-5D-5L) and condition-specific (DEMQOL-U and DEMQOL-Proxy-U) 
preference-based HRQoL instruments in residential care, where the population is characterised by older people with high 
rates of cognitive impairment, dementia and disability.
Methods Participants were recruited from seventeen residential care facilities across four Australian states. One hundred 
and forty-three participants self-completed the EQ-5D-5L and the DEMQOL-U while three hundred and eight-seven proxy 
completed (due to the presence of severe dementia) the EQ-5D-5L and DEMQOL-Proxy-U. The convergent validity of the 
outcome measures and known group validity relative to a series of clinical outcome measures were assessed.
Results Results satisfy convergent validity among the outcome measures. EQ-5D-5L and DEMQOL-U utilities were found 
to be significantly correlated with each other (p < 0.01) as were EQ-5D-5L and DEMQOL-Proxy-U utilities (p < 0.01). Both 
self-reported and proxy-reported EQ-5D-5L utilities demonstrated strong known group validity in relation to clinically rec-
ognised thresholds of cognition and physical functioning, while in contrast neither DEMQOL-U nor DEMQOL-Proxy-U 
demonstrated this association.
Conclusions The findings suggest that the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U capture distinct aspects of 
HRQoL for this population. The measurement and valuation of HRQoL form an essential component of economic evalua-
tion in residential care. However, high levels of cognitive impairment may preclude self-completion for a majority. Further 
research is needed to determine cognition thresholds beyond which an individual is unable to reliably self-report their own 
health-related quality of life.
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Introduction
There is ongoing debate surrounding the ability of people 
with cognitive impairment and dementia to self-report their 
own health-related quality of life (HRQoL) [1, 2]. This issue 
is of particular importance for quality of life assessment and 
economic evaluations conducted in a residential care set-
ting, where the majority of residents are living with cogni-
tive impairment and dementia [3–6]. Presently, over 50% of 
residents in Australian residential aged care facilities have 
a diagnosis of dementia and estimates indicate that up to 
75% are living with some form of cognitive impairment [3].
The EQ-5D is a generic preference-based instrument for 
the measurement and valuation of HRQoL that is widely 
applied in economic evaluation. It is well known for its 
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reliability, responsiveness and validity in adults with good 
cognitive functioning [7]. The acceptability and feasibility 
of the EQ-5D for administration with individuals exhibiting 
mild to moderate cognitive impairment and living in residen-
tial aged care have been demonstrated in a number of pub-
lished studies internationally [8–13]. For individuals who 
are unable to self-complete, the EQ-5D due to more severe 
levels of cognitive impairment, proxy assessment is neces-
sary. A recent systematic review found proxy assessment 
of HRQoL to be most acceptable across the entire range of 
Alzheimer’s disease severity in terms of validity and reli-
ability in detecting long-term changes relevant to economic 
evaluations [14]. The use of proxy assessors raises the ques-
tion of who is the most appropriate proxy. Several studies 
have indicated that the choice of proxy respondent may also 
affect assessment of quality of life [13, 15]. A recent study 
undertaken in Spain by Diaz-Redondo and colleagues found 
that quality of life as measured by the EQ-5D was rated 
higher by staff members caring for people with dementia 
compared to ratings given by family members [16].
The DEMQOL and DEMQOL-Proxy were developed as 
condition-specific instruments to capture the measurement 
of HRQoL of individuals with cognitive decline and demen-
tia where the DEMQOL was designed to be self-completed 
by the individual and the DEMQOL-Proxy was designed to 
be completed by a suitable proxy, e.g. close family member 
or a carer [17, 18]. In their original form, both the DEMQOL 
and the DEMQOL-Proxy are not suitable for use in eco-
nomic evaluation as they provide summary scores that are 
not preference based. However, the recent development of 
the DEMQOL-U and DEMQOL-Proxy-U using general 
population preference values has facilitated the application 
of these measures in economic evaluations [19, 20].
A number of adjustments to the original EQ-5D instru-
ment have emerged in recent years in a bid to improve vari-
ous aspects of the instrument. An extended version of the 
EQ-5D was developed to incorporate a cognitive dimension 
in an effort to improve content validity [8]. This cognitive 
“bolt-on” has not yet been explored in depth, and it has not 
been incorporated into the scoring algorithm for the EQ-5D 
[9]. The recent development of a five-level version of the 
EQ-5D has improved its sensitivity compared to the origi-
nal three-level version with an increase from 243 to 3125 
unique health states [10]. To date, the five-level version of 
the EQ-5D has not been widely applied in residential care 
settings where the population is characterised by high rates 
of cognitive impairment, dementia and disability [11].
The main aim of this study was to empirically compare 
the measurement properties of the new five-level version of 
the EQ-5D (EQ-5D-5L), a generic preference-based measure 
of HRQoL with the DEMQOL-U and DEMQOL-Proxy-U 
condition-specific preference-based measures for older peo-
ple living in residential care with cognitive impairment and 
dementia. Specifically, we assessed the convergent validity 
of the outcome measures relative to each other and relative 
to a battery of validated clinical outcome measures to assess 
cognition, functioning and neuropsychiatric symptoms for 
the self-reported and proxy-reported subgroups. We also 
assessed known group validity, a form of construct validity, 
by comparing the utilities derived from each instrument rela-
tive to the recognised severity thresholds relating to cogni-
tion and physical functioning.
Methods
Study participants
The data utilised for this study were derived from the 
INSPIRED (Investigating services provided in the residential 
care environment for dementia) study. The INSPIRED study 
was a cross-sectional, observational study to evaluate the 
specialised dementia services provided at residential aged 
care facilities in Australia. Data were collected from 17 resi-
dential aged care facilities across 4 states over a 14-month 
time period from January 2015 to February 2016. Residents 
were eligible to participate in this study if they (1) were 
permanent residents of the facility; (2) had been residing in 
the facility for at least 12 months; (3) were not in immediate 
palliative care; (4) had no complex medical or family issues 
which would impede their participation; and (5) had a family 
member willing to participate on their behalf if the resident 
themselves was unable to provide informed consent due to 
the presence of significant cognitive impairment.
Data collection
The INSPIRED study involved the administration of a com-
prehensive set of outcome measurements, including generic 
and condition-specific measurements of health-related qual-
ity of life (assessed by the resident or proxy), cognitive func-
tion, dementia severity, physical function and neuropsychi-
atric symptoms (assessed by a care staff nurse).
PAS‑Cog
The Psychogeriatric Assessment Scales (PAS) are a collec-
tion of 6 scales which provide an assessment of dementia 
and depression in older adults [21]. The Cognitive Impair-
ment scale consists of 9 questions administered in the form 
of an interview to test the cognitive functioning and memory 
of the subject. The resulting score ranges between 0 and 21, 
with 0 indicating that no impairment was detected by the 
scale and 21 indicating severe cognitive impairment.
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EQ‑5D‑5L
The EQ-5D-5L is a generic, preference-based instrument 
for the measurement and valuation of HRQoL [11]. The 
EQ-5D-5L can be completed by the subject or by a proxy, 
and collects subjective assessments of mobility, self-care, 
usual activities, pain/discomfort and anxiety/depression. 
Self-completion of the EQ-5D-5L was encouraged for all 
participating residents with a PAS-Cog score ≤ 11, based 
on evidence of its appropriateness in people with mild 
to moderate dementia [13, 22]. Health state utility val-
ues were generated from a scoring algorithm based on 
the time trade off (TTO) and discrete choice experiment 
(DCE) approaches in a UK general population sample 
[23]. Utility scores are bounded from − 0.281 to 1 where 
health states with a score less than 0 are considered worse 
than death. We also included a cognition bolt-on question 
which was originally developed for the 3-level version of 
the EQ-5D instrument [8]. The individual responses to 
the bolt-on question were not incorporated into the utility 
scoring algorithm as currently there is no recommended 
approach for facilitating this.
DEMQOL‑U and DEMQOL‑Proxy‑U
The DEMQOL and DEMQOL-Proxy are health-related 
quality of life instruments designed specifically for use 
in people with dementia [18]. The DEMQOL is a self-
report instrument containing 28 items and is appropriate 
for use in people with mild to moderate dementia. Individ-
ual responses to the DEMQOL were converted to health 
state utility values using the DEMQOL-U scoring algo-
rithm derived using the TTO approach in a UK general 
population sample [19]. The DEMQOL-U consists of four 
levels of severity in five dimensions: positive emotion, 
memory, relationships, negative emotion and loneliness. 
Utility scores for the DEMQOL-U are bounded from 0.243 
to 0.986 [19]. The DEMQOL-Proxy, which contains 31 
items, is designed for completion by a family member or 
carer. The DEMQOL-Proxy instructs proxies to provide 
responses to the instrument that most closely approximate 
the responses that they think the resident would provide 
themselves were they cognitively able to do so (proxy-
resident perspective). Responses to the DEMQOL-Proxy 
were converted to health state utility values using the 
DEMQOL-Proxy-U scoring algorithm derived using the 
TTO approach in a UK general population sample [19]. 
The DEMQOL-Proxy-U consists of four levels of severity 
in four dimensions: positive emotion, memory, appearance 
and negative emotion. Utility scores for the DEMQOL-
Proxy-U are bounded from 0.363 to 0.937 [19].
Modified Barthel Index (MBI)
The MBI is a functional assessment scale which measures 
a person’s level of independence across a range of activities 
of daily living (ADL) functions [24]. Consisting of 10 items, 
the MBI is scored on a range from 0 to 100, with 0 indicat-
ing full dependence in all categories and 100 indicating full 
independence.
Neuropsychiatric inventory questionnaire (NPI‑Q)
The NPI-Q, a brief version of the original Neuropsychiatric 
Inventory, is a validated instrument for assessing psycho-
pathology in dementia [25]. There is both a 10-item and 
12-item version. The 10-item NPI-Q was completed by care 
staff for each participating resident in the INSPIRED study. 
Each of the items was rated by the care staff as 0–3 points 
according to levels of increasing severity with 0 indicating 
no symptoms were present in the past month, and 3 indicat-
ing severe symptoms were present.
Recruitment process
The Psychogeriatric Assessment Scales–Cognitive Impair-
ment Scale (PAS-Cog) was used to ascertain an eligible resi-
dent’s level of cognitive impairment [21]. PAS-Cog scores 
were collected from facility records if the assessment had 
occurred within 3 months of data collection and/or the indi-
vidual had severe cognitive impairment (PAS-Cog ≥ 18). 
For all other participants, the PAS-Cog was administered 
by trained data collection personnel. Using PAS-Cog scores 
and/or advice from facility care staff, residents were sepa-
rated into two separate consent profiles based on their likely 
ability to give informed consent and an appropriate recruit-
ment approach was undertaken for each group. Residents 
who scored between 0 and 9 on the PAS-Cog (indicating no 
to mild cognitive impairment) were provided with informa-
tion on the full INSPIRED study, and given time to con-
sider whether they wished to participate. Proxy consent 
from a family member was sought for all eligible residents 
with moderate to severe cognitive impairment, or where 
the researcher had doubt regarding a resident’s ability to 
self-consent. Family members were initially sent the study 
information pack via post and then approached by telephone 
to determine whether they were interested in participating 
on behalf of the resident. Proxy consent was sought and 
completed by a family member, spouse or friend empowered 
with legal decision-making authority.
All outcome measures were collected via face-to-face 
interviews where possible. Where proxy consent was 
obtained, the proxy was invited to the aged care facility for 
a personal interview. If a personal interview was not pos-
sible, questionnaire packs were sent to the proxy via post 
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with an option to either complete the questionnaires via a 
telephone interview or in their own time from the perspec-
tive of the resident.
Statistical analysis
Summary statistics for the total INSPIRED study sample 
and the sub-samples of participants who self-completed 
and proxy completed the HRQOL instruments (EQ-5D-5L, 
DEMQOL-U and DEMQOL-Proxy-U) were calculated for 
all demographic and outcome measures. The distribution of 
each variable was assessed for normality using the Kolmog-
orov–Smirnov test with Lilliefors significance correction 
and the Shapiro–Wilks test. Utility distributions were plotted 
for the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U. 
The Mann–Whitney U test and the Kruskal–Wallis test were 
used to compare utility scores across subgroups.
The strength of association between the dimensions of 
the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U were 
evaluated using Spearman’s rank order correlations and 
Index-level correlations were graphically represented with 
scatterplots. Correlation sizes below 0.3 were considered 
weak, those from 0.3 to < 0.5 were considered moderate, and 
those from 0.5 to < 0.6 were considered strong, and those 
of 0.6 or greater were considered very strong [19, 26]. The 
level of agreement between the HRQoL instruments was 
also graphically presented using Bland–Altman plots [27]. 
Differences in individual-level utility scores were plotted 
on the y axis, and average utility scores were plotted on the 
x axis. For each Bland–Altman plot, a mean difference was 
calculated along with 95% limits of agreement (LOA), equal 
to the mean difference ± 1.96 standard deviations of the dif-
ference. A mean difference value that differed significantly 
from 0 indicated the presence of a fixed bias. The limits of 
agreement indicated how far apart measurements by each 
instrument were likely to be for an individual.
Convergent validity for the EQ-5D-5L and the DEMQOL-
U was assessed by examining the mean distributions of 
DEMQOL-U utilities by EQ-5D-5L dimensions. Convergent 
validity was also assessed between each HRQoL instrument 
and three common clinical outcome measures for demen-
tia: cognitive function, physical function and neuropsy-
chiatric symptoms. Bivariate correlation coefficients were 
calculated for each HRQoL dimension with the respective 
clinical outcome measures (PAS-Cog, MBI, and NPI-Q). 
Known- group validity was assessed using clinically severity 
thresholds PAS-Cog and MBI. Specifically, we hypothesised 
that participants with no to mild cognitive impairment (PAS-
Cog score 0–9) would have higher utilities relative to those 
with moderate (PAS-Cog score 9–15) and severe (PAS-Cog 
score 16–21) impairment. Similarly, we hypothesised that 
participants with better physical functioning as measured by 
the MBI would have higher utilities than those with worse 
physical functioning. Effect size indices were also calculated 
to provide an indication of the average group difference tak-
ing into account the variability observed in the group with 
least impairment (PAS-Cog score 0–3; MBI score = 100). 
Based on commonly cited guidelines, values of 0.2, 0.5 and 
0.8 denote small, medium and large effect sizes, respectively 
[28].
Results
The INSPIRED study assessed a total of 1323 people living 
in 17 residential care facilities across 4 Australian states. 
The facilities belonged to 5 not-for-profit aged care organisa-
tions. Of the total resident pool, 901 met eligibility require-
ments and 541 were consented to the study. A total of 24% 
of study participants self-consented, while proxy consents 
were obtained for 76%. The mean (SD) age of participants 
was 85.5 (8.5) years. Descriptive statistics for the INSPIRED 
study sample as well as the subgroups who self-reported and 
proxy-reported HRQOL are presented in Table 1.
In the full INSPIRED study sample (n = 541), a measur-
able level of cognitive impairment was present in 83% of 
participants and 64% had a recorded diagnosis of demen-
tia. Among the subset of 143 participants who were able 
to complete both the DEMQOL-U and EQ-5D-5L instru-
ments, 45% were identified as living with mild or moderate 
cognitive impairment, and 25% had a diagnosis of demen-
tia. Among the sub-sample of 387 participants for which 
both the DEMQOL-Proxy-U and EQ-5D-5L instruments 
were completed by proxy, 77% had a recorded diagnosis of 
dementia. Twenty-one participants in the proxy-rated sub-
group were unable to complete the PAS-Cog due to severe 
cognitive impairment.
For the self-completion sub-sample neither the EQ-5D-5L 
nor DEMQOL-U instruments produced normally distributed 
values according to the Kolmogorov–Smirnov test with Lil-
liefors significance correction and the Shapiro–Wilks test. 
A negative skew was observed for both instruments (Fig. 1). 
No significant differences in utility scores were found 
between males and females for either instrument. EQ-5D-5L 
utility values tended to increase with age (p = 0.033), with 
the older residents reporting higher utility scores on average 
than younger residents. This age-related trend was not found 
in DEMQOL-U scores. Mean EQ-5D-5L utility scores were 
higher for residents with a diagnosis of dementia compared 
to those without diagnosed dementia and these differences 
were found to be statistically significant (p = 0.001). This 
pattern was also evident for the DEMQOL-U, with slightly 
higher scores reported on average for those with a diagnosis 
of dementia, however, this difference was not found to be 
statistically significant (p = 0.105).
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Table 1  Sample characteristics and summary statistics for the INSPIRED study sample and self-rated HRQoL subgroup
Variable INSPIRED study sample Self-rated HRQoL subgroup Proxy-rated HRQoL subgroup
N Mean (SD) or % Range N Mean (SD) or % Range N Mean (SD) or % Range
Participant characteristics
 Age (years) 541 85.5 (8.5) 48–104 143 85.7 (8.8) 49–99 387 85.5 (8.3) 48–104
 Female 403 74. 5 – 103 72.0 – 290 74.9 –
 Diagnosis of dementia 345 64.0 – 35 24.5 – 299 77.3 –
Self-rated HRQoL utility values
 EQ-5D-5L 151 0.66 (0.29) – 0.28 to 1.00 143 0.66 (0.28) – 0.28 to 1.00 – – –
 DEMQOL-U 225 0.85 (0.12) 0.30–0.99 143 0.87 (0.12) 0.39–0.99 – – –
Proxy-rated HRQoL utility values
 EQ-5D-5L-Proxy 390 0.48 (0.29) – 0.28 to 1.00 – – – 387 0.48 (0.29) – 0.28 to 1.00
 DEMQOL-Proxy-U 536 0.69 (0.13) 0.36–0.94 – – – 387 0.68 (0.13) 0.36–0.94
Clinical outcome measures
 PAS-Cog score (max 21) 520 13.2 (7.7) 0–21 143 3.75 (2.8) 0–11 366 16.6 (5.9) 0–21
 Modified Barthel Index 
(max 100)
537 40.2 (32.7) 0–100 143 63.0 (30.0) 0–100 383 32.9 (29.8) 0–100
 NPI-Q 10 item sum 
severity (max 30)
538 8.3 (6.4) 0–28 143 4.9 (4.7) 0–25 384 9.5 (6.5) 0–28
Fig. 1  Distribution of EQ-5D-5L and DEMQOL-U, EQ-5D-5L-Proxy and DEMQOL-Proxy-U utility scores
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For the proxy-completed sub-sample, similarly neither the 
EQ-5D-5L nor DEMQOL-Proxy-U instruments produced 
normally distributed values according to the Kolmogo-
rov–Smirnov test with Lilliefors significance correction and 
the Shapiro–Wilks test. The distributions of utility scores for 
the completed by proxy are shown in Fig. 1. No significant 
differences in utility scores were found between males and 
females for either instrument. No associations were found 
between utility scores and resident age for either instrument. 
Mean EQ-5D-5L proxy utility scores were slightly higher for 
residents with a diagnosis of dementia compared to those 
without diagnosed dementia; however, the difference was not 
statistically significant (p = 0.314). Mean DEMQOL-Proxy-
U utility scores were the same for residents with and without 
a diagnosis of dementia.
The Spearman correlation coefficients between the EQ-
5D-5L and DEMQOL-U and EQ-5D-5L and DEMQOL-
Proxy-U, respectively, are presented in Table 2, and graphi-
cally in Fig. 2. Generally speaking, for both sub-samples, 
the correlations were weak to moderate across all dimen-
sions. Eleven participants described themselves in full health 
according to the EQ-5D-5L but also with at least some 
impairment in the DEMQOL-U. Similarly, eleven partici-
pants were described in full health according to the EQ-
5D-5L by proxy but also with at least some impairment in 
the DEMQOL-Proxy-U. In contrast, 8 participants described 
themselves in full health according to the DEMQOL-U 
while their corresponding EQ-5D-5L scores indicated a 
range of impairments and 3 participants were described in 
full health according the DEMQOL-Proxy-U while their 
corresponding EQ-5D-5L scores also indicated a range of 
impairments.
The agreements between utility scores generated by 
the EQ-5D-5L and DEMQOL-U, and EQ-5D-5L and 
DEMQOL-Proxy-U, respectively, are graphically presented 
in Fig. 3. The mean difference for the self-reported instru-
ments was 0.206, with the 95% LOA ranging from − 0.314 
to 0.725. The mean difference for the proxy-rated instru-
ments was 0.202, with the 95% LOA ranging from − 0.321 
to 0.726. For both sub-samples, there is evidence of a higher 
level of agreement between instruments at higher levels of 
utility, with more responses clustering around the zero mean 
difference. At lower levels of utility both the DEMQOL-U 
and DEMQOL-Proxy-U produce consistently higher utility 
values than the EQ-5D-5L.
The correlations between the HRQoL dimensions and 
clinical outcome measures are presented in Table 3. For 
both sub-samples, overall, the correlations between the 
EQ-5D-5L and clinical outcome measures were stronger 
than between the DEMQOL-U/DEMQOL-Proxy-U and 
clinical outcome measures. In both sub-samples, physical 
functioning as measured by the MBI showed a moderately 
Table 2  Spearman correlation coefficients of EQ-5D-5L, DEMQOL-U, and DEMQOL-Proxy-U measures
*Correlation is significant at the 0.05 level (2-tailed)
**Correlation is significant at the 0.01 level (2-tailed)
Self-reported HRQoL measures
Positive emotion Negative emotion Loneliness Cognition Relationships DEMQOL-U Index
Mobility 0.150 − 0.059 − 0.048 − 0.154 − 0.215** − 0.134
Self-care 0.251** − 0.157 − 0.181* − 0.125 − 0.191* − 0.267**
Usual activities 0.163 − 0.260** − 0.262** − 0.156 − 0.324** − 0.351**
Pain and discomfort 0.151 − 0.203* − 0.215** − 0.220** − 0.194* − 0.294**
Anxiety and depression 0.278** − 0.371** − 0.204* − 0.253** − 0.177* − 0.374**
Cognition 0.181* − 0.158 − 0.120 − 0.304** − 0.234** − 0.222**
EQ-5D-5L Index − 0.231** 0.255** 0.216** 0.216** 0.321** 0.346**
Proxy-reported HRQoL measures
Negative emotion Positive emotion Memory Appearance DEMQOL-Proxy-U Index
Mobility − 0.106* 0.282** 0.049 0.021 − 0.265**
Self-care − 0.036 0.307** 0.058 0.055 − 0.248**
Usual activities − 0.077 0.344** 0.022 0.058 − 0.306**
Pain and discom-
fort
− 0.338** 0.079 − 0.131* − 0.136** − 0.249**
Anxiety and 
depression
− 0.381** 0.131** − 0.232** − 0.146** − 0.334**
Cognition 0.025 0.243** − 0.005 0.128* − 0.177**
EQ-5D-5L Index 0.251** -0.325** 0.049 0.027 0.389**
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strong correlation with EQ-5D-5L utilities, particularly in 
the dimensions of “mobility”, “self-care” and “usual activi-
ties” with greater impairments being associated with lower 
reported quality of life. Higher levels of cognitive impair-
ment, as measured by the PAS-Cog, were associated with 
higher self-reported quality of life as measured by the EQ-
5D-5L, particularly in the dimensions of “mobility”, “self-
care” and “pain and discomfort”, although the strength of 
the correlation (r = 0.24) was weak. Behavioural and psycho-
logical symptoms, as measured by the NPI-Q, were weakly 
correlated with the DEMQOL-U Index and the dimension 
of “loneliness” in particular with more severe symptoms 
associated with higher reported loneliness and lower quality 
of life overall. Behavioural and psychological symptoms, as 
measured by the NPI-Q, were weakly correlated with the 
DEMQOL-Proxy-U dimension of “negative emotion”. There 
was also a weak to negligible correlation between physi-
cal function and the “positive emotion” and “appearance” 
dimensions of the DEMQOL-Proxy-U with better function 
associated with higher positive emotion and appearance.
Table 4 indicates that no particularly strong relation-
ships were evident between proxy-reported HRQoL utili-
ties and cognitive impairment. There was a relationship 
between self-reported EQ-5D-5L and cognitive impair-
ment although this was not in the expected direction. Par-
ticipants with more severe cognitive impairment reported 
Fig. 2  Scatterplot of EQ-5D-5L and DEMQOL-U, and EQ-5D-5L-Proxy and DEMQOL-Proxy-U utility values
Fig. 3  Bland–Altman plots analysing agreement between EQ-5D-5L and DEMQOL-U, and EQ-5D-5L-Proxy and DEMQOL-Proxy-U
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themselves with higher HRQoL than those with lower 
levels of cognitive impairment. This relationship was also 
evident for the DEMQOL-U but the differences in mean 
values were not as pronounced. However, these results 
should be interpreted with caution as the effect sizes are 
small and the n is particularly small for the moderate 
impairment group. Table 4 also indicates that EQ-5D-5L 
scores decrease across physical function severity groups 
in the expected direction for both the self-reported and 
proxy-completed sub-samples and the effect sizes are in 
the small to moderate range. The DEMQOL-Proxy-U 
scores also decreased across physical function severity 
groups in the expected direction but the differences were 
not as pronounced as for the EQ-5D-5L.
Discussion
This study presents one of the first empirical compari-
sons in Australia and internationally of the measurement 
properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-
Proxy-U instruments and represents the first study inter-
nationally to empirically compare the measurement prop-
erties of these instruments in a residential care setting. 
Table 3  Spearman correlation 
coefficients of EQ-5D-5L and 
DEMQOL-U measures with 
clinical outcome measures
*Correlation is significant at the 0.05 level (2-tailed)
**Correlation is significant at the 0.01 level (2-tailed)







  Mobility − 0.230** − 0.499** 0.018
  Self-care − 0.237** − 0.609** 0.069
  Usual activities − 0.087 − 0.374** 0.140
  Pain and discomfort − 0.194* − 0.065 0.143
  Anxiety and depression − 0.004 − 0.050 0.076
  Cognition 0.025 − 0.039 0.045
  EQ-5D-5L Index 0.243** 0.492** − 0.099
 DEMQOL-U
  Positive emotion − 0.047 − 0.183* 0.102
  Negative emotion 0.011 0.119 − 0.116
  Loneliness 0.028 0.010 − 0.201*
  Cognition − 0.100 0.003 − 0.043
  Relationships − 0.062 0.094 − 0.003
  DEMQOL-U Index 0.066 0.105 − 0.183*
Proxy-reported HRQoL
 EQ-5D-5L-Proxy
  Mobility 0.215** − 0.555** − 0.177**
  Self-care 0.386** − 0.627** − 0.063
  Usual activities 0.356** − 0.577** − 0.083
  Pain and discomfort − 0.067 − 0.055 0.006
  Anxiety and depression − 0.043 0.000 0.160**
  Cognition 0.495** − 0.488** 0.062
  EQ-5D-5L Index − 0.261** 0.560** 0.056
 DEMQOL-Proxy-U
  Negative emotion 0.023 − 0.058 − 0.231**
  Positive emotion 0.108* − 0.147** − 0.051
  Memory 0.124* − 0.131* − 0.069
  Appearance 0.163** − 0.133** − 0.013
  DEMQOL-Proxy-U Index − 0.048 0.069 − 0.057
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The central importance of proxy assessment of HRQoL 
in this setting is highlighted, with 75% of our study par-
ticipants having insufficient cognitive ability to self-assess 
their own HRQoL. With the exception of the moderate 
correlation found between physical function and the EQ-
5D-5L, the clinical outcome measures for people with 
dementia—cognition, physical function and neuropsy-
chological symptoms—showed little association with the 
utility scores produced by the EQ-5D-5L and DEMQOL-U 
instruments. This is consistent with the findings of other 
studies conducted in older people living with cognitive 
impairment and/or dementia in community-based settings 
which have reported little or no association between clini-
cal outcome measures for dementia and self-reported qual-
ity of life as measured by the EQ-5D-3L [19, 29–31] and 
DEMQOL-U [19].
Higher levels of cognitive impairment were associated 
with higher self-reported EQ-5D-5L utilities. Interestingly, 
overall mean utility scores for residents with a diagnosis of 
dementia were higher than for those without a diagnosis of 
dementia. It is possible that people admitted to residential 
care without a diagnosis of dementia have more severe phys-
ical disabilities than those with a dementia diagnosis and 
this could account for such differences. Previous research 
conducted in Australia has found people living in residen-
tial aged care facilities with a diagnosis of dementia tend 
to have higher care needs on average than those without in 
relation to activities of daily living and behaviour [3]. In 
our sample, however, the subgroup without dementia had 
a lower MBI score on average indicating a higher level of 
dependence, while the subgroup with dementia had a higher 
average NPI-Q sum score and higher average PAS-Cog score 
suggesting more cognitive impairment and more behav-
ioural and psychological symptoms than residents without 
a dementia diagnosis. This finding was not repeated in the 
proxy-rated subgroup and these results should be interpreted 
Table 4  Self-reported and Proxy-reported HRQoL utilities (mean and SD) by clinical determinants (PAS-Cog, and MBI)
The Kruskal–Wallis test was used to calculate p values when testing for differences across known groups. The Mann–Whitney U test was then 
used to calculate effect size between groups. Effect size was calculated by dividing Z by the square root of N
Sample Characteristic N EQ-5D-5L DEMQOL-U/DEMQOL-
Proxy-U
Mean (SD) Effect size Mean (SD) Effect size
Self-Reported HRQoL Cognitive impairment
 No or minimal (PAS-Cog score 0–3) 78 0.61 (0.29) – 0.86 (0.11) –
 Mild (PAS-Cog score 4–9) 60 0.70 (0.27) 0.18 0.86 (0.12) 0.04
 Moderate (PAS-Cog score 10–15) 5 0.95 (0.08) 0.31 0.91 (0.06) 0.08
 Severe (PAS-Cog score 16–21) 0 – – – –
 p value 0.002 0.667
Physical function
 Independence (MBI score 100) 11 0.87 (0.12) – 0.90 (0.08) –
 Slight dependence (MBI score 91–99) 22 0.73 (0.22) 0.36 0.87 (0.09) 0.19
 Moderate dependence (MBI score 61–90) 52 0.74 (0.24) 0.05 0.87 (0.12) 0.12
 Severe dependence (MBI score 21–60) 38 0.61 (0.26) 0.29 0.84 (0.12) 0.20
 Total dependence (MBI score 0–20) 24 0.37 (0.32) 0.38 0.87 (0.13) 0.23
 p value < 0.001 0.154
Proxy-Reported HRQoL Cognitive impairment
 No or minimal (PAS-Cog score 0–3) 16 0.50 (0.34) – 0.62 (0.09) –
 Mild (PAS-Cog score 4–9) 43 0.60 (0.29) 0.11 0.71 (0.13) 0.27
 Moderate (PAS-Cog score 10–15) 64 0.53 (0.25) 0.15 0.69 (0.14) 0.08
 Severe (PAS-Cog score 16–21) 243 0.44 (0.30) 0.15 0.67 (0.13) 0.01
 p value 0.001 0.277
Physical function
 Independence (MBI score 100) 2 0.84 (0.14) – 0.83 (0.15) –
 Slight dependence (MBI score 91–99) 14 0.73 (0.11) 0.24 0.75 (0.11) 0.28
 Moderate dependence (MBI score 61–90) 69 0.67 (0.23) 0.08 0.69 (0.13) 0.15
 Severe dependence (MBI score 21–60) 128 0.57 (0.27) 0.18 0.68 (0.13) 0.02
 Total dependence (MBI score 0–20) 169 0.31 (0.25) 0.47 0.67 (0.13) 0.04
 p value < 0.001 0.134
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with caution as the effect sizes were small. Proxy-rated util-
ity values did not differ between residents with and without 
dementia. While this may seem counterintuitive, especially 
for a dementia-specific instrument like the DEMQOL-
Proxy-U, it is consistent with the existing literature which 
has found no association between quality of life measures 
and cognitive function or dementia severity [32, 33]. The 
implication of this finding, as highlighted in Banerjee et al. 
[32], is that discrete measures such as cognition are likely 
to miss important factors which contribute to better quality 
of life in residential care.
In terms of the utility scores generated by the EQ-5D-5L 
and DEMQOL-U, the mean difference was 0.2 with util-
ity scores generated by the EQ-5D-5L tending to be lower 
than those generated by the DEMQOL-U. The 95% LOA 
indicated that DEMQOL-U scores tended to range from 0.7 
above their corresponding EQ-5D-5L score to 0.3 below. 
This apparent disagreement must be interpreted with cau-
tion given the different lower bound of each instrument. 
Despite both instruments providing a score on the theoreti-
cal 0 = dead − 1 = full health utility scale required for the 
calculation of quality adjusted life years (QALYS) the find-
ings from this study indicate that the DEMQOL-U is not 
an appropriate substitute for the EQ-5D-5L and vice-versa.
Our data suggest that the DEMQOL-U and EQ-5D-5L 
capture distinct and unique aspects of HRQoL as indicated 
by poor agreement and low to negligible correlations across 
all dimensions. Ceiling effects were apparent for both the 
EQ-5D-5L and DEMQOL-U dimensions which is a com-
monly reported occurrence in self-reported measures for 
people with dementia [13, 19, 22]. The DEMQOL-U dem-
onstrated a reasonable ability to discriminate between the 
dimensions of the EQ-5D-5L, with utility scores tending 
to decrease as EQ-5D-5L dimensions worsened. This pat-
tern was much more consistent in the more psycho-social 
dimensions “pain and discomfort”, “anxiety and depression” 
and “cognition” compared to the more physical dimensions 
of “mobility”, “self-care” and “usual activities”. This may 
be explained by the psycho-social nature of the DEMQOL-
U dimensions. In contrast, the EQ-5D-5L was found to be 
more strongly related to physical functioning as assessed by 
the MBI. The EQ-5D-5L may therefore be a more suitable 
instrument for the assessment of HRQoL in mixed residen-
tial care populations that include people with dementia but 
also people with co-morbidities, high levels of physical dis-
ability and frailty with good cognition.
Both instruments collected data on a “cognition” dimen-
sion, although the cognition dimension was not included in 
the Index-score calculation for the EQ-5D-5L. The cogni-
tion dimension had only a low positive correlation (r = 0.3, 
p < 0.01) between the two instruments. It is possible that this 
empirical difference is related to the differential framing of 
the question relating to cognition for each instrument. The 
EQ-5D-5L asks participants to answer to best describe how 
they are feeling today with the cognition dimension options 
ranging from “I do not have any problems with cognitive 
functioning” to “I have extreme problems with cognitive 
functioning”. In contrast, the DEMQOL asks participants 
“In the last week how worried have you been about forget-
ting things that happened recently?” with possible responses 
ranging from “a lot” to “not at all”.
It is important to note that the majority of previous stud-
ies reporting upon the HRQoL of people with dementia have 
predominantly been conducted in community based settings. 
Of the small number of recent studies investigating quality of 
life in a residential care setting, the vast majority have used 
proxy-rated instruments [16, 34] and/or mapping techniques 
[35] to elicit health state values for people with dementia. 
Similarly, a study measuring quality of life among hospital 
in-patients with dementia concluded that proxy-ratings were 
the only feasible option [36]. We have demonstrated that 
self-assessment of own HRQoL is feasible for at least a pro-
portion of people living in residential care. Self-assessment 
of HRQoL by residents themselves is preferable where pos-
sible [7]. Given the results of our analyses, we are inclined 
to conclude that proxy-rated measures of HRQoL may be a 
practical option for the elicitation of health state values for 
use in cost–utility analyses in a residential aged care setting 
in order to ensure a consistently representative study sample 
and to facilitate longitudinal assessment of the HRQoL of 
all residents. Above and beyond practicality, however, there 
are important ethical considerations in deciding whether 
to use self or proxy measures. This study did not directly 
compare self and proxy versions of the same instrument, 
rather it compared generic with dementia-specific instru-
ments for distinct self and proxy subgroups. The results of 
studies which directly compare self and proxy responses for 
the same participants should also be considered, along with 
factors such as proxy bias [37–39].
There are several limitations to our study. Participa-
tion at organisational level, facility level and individual 
level was voluntary and thus the participants in this study 
may not be representative of the Australian residential care 
population. The scoring algorithms for both the EQ-5D-5L 
and DEMQOL-U were from a UK general population 
sample despite the study having taken place in Australia. 
Further empirical analyses are warranted when Australian 
scoring algorithms become available, as utilities for identi-
cal health states have been shown to differ across countries 
and jurisdictions [40, 41]. It should also be noted that the 
UK EQ-5D-5L scoring algorithm has been revised since 
our analysis was completed [42]. Changes in the revised 
algorithm were minor and the Euroqol group notes that 
the practical implications of these changes are relatively 
small. We are therefore highly confident that this change 
will not affect the overall conclusions of our research. 
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Future studies conducted in the Australian context should 
use the updated UK algorithm until the Australian EQ-
5D-5L general population-specific scoring algorithm, 
currently in development, becomes publically available. 
Finally, as the study was cross-sectional in nature, it was 
not possible to assess either instrument’s responsiveness 
to change over time, an important criteria for the conduct 
of economic evaluation studies.
Conclusions
The EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U 
capture distinct aspects of HRQoL which provide use-
ful complements to clinical outcome measures for people 
with dementia. Although these instruments were designed 
to measure the same concept of utility on an equivalent 
quality adjusted life years (QALY) scale, it is apparent that 
QALYs produced by the condition-specific DEMQOL-U are 
not directly comparable with QALYs produced by the EQ-
5D-5L. Researchers and decision-makers should therefore be 
cautious in their interpretation of cost–utility analyses and 
pay careful attention to the outcome measures used in the 
assessment of effectiveness and the calculation of QALYs. 
With its strong association with physical functioning, the 
EQ-5D-5L may be a more suitable instrument for the assess-
ment of HRQoL in mixed residential care populations that 
include people with dementia but also people with co-mor-
bidities, high levels of physical disability and frailty with 
good cognition. The DEMQOL-U and DEMOL-Proxy-U, 
on the other hand, may be suitable for dementia-specific 
interventions that are more psycho-social in nature.
The measurement and valuation of HRQoL provide an 
important outcome which is highly relevant for quality 
assessment and economic evaluations conducted in resi-
dential care settings. Further research should be directed 
towards informing the highly important but vexed question 
as to the level of cognitive impairment beyond which an 
individual is unable to reliably self-report generic prefer-
ence-based health-related quality of life instruments, includ-
ing the EQ-5D, and beyond which proxy assessment should 
be sought.
Acknowledgements These authors gratefully acknowledge fund-
ing provided by the National Health and Medical Research Council 
(NHMRC) Partnership Centre on Dealing with Cognitive and Related 
Functional Decline in Older People (Grant No. GNT9100000). The 
contents of the published materials are solely the responsibility of 
the Administering Institution, Flinders University, and the individual 
authors identified, and do not reflect the views of the NHMRC or any 
other Funding Bodies or the Funding Partners. Tiffany Easton is sup-
ported by a PhD scholarship from the NHMRC Partnership Centre 
on Dealing with Cognitive and Related Functional Decline in Older 
People and an Australian Government Research Training Program 
Scholarship. The authors sincerely thank the INSPIRED study partici-
pants and their family members for their participation and interest in 
the study. The assistance of facility staff, care worker researchers and 
data collectors in each state is gratefully acknowledged for their efforts.
 Open Access This article is distributed under the terms of the Creative 
Commons Attribution 4.0 International License (http://creativecom-
mons.org/licenses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Berwig, M., Leicht, H., & Gertz, H. J. (2009). Critical evaluation 
of self-rated quality of life in mild cognitive impairment and Alz-
heimer’s disease - further evidence for the impact of anosognosia 
and global cognitive impairment. The Journal of Nutrition, Health 
and Aging, 13(3), 226–230.
 2. Conde-Sala, J. L., Turró-Garriga, O., Garre-Olmo, J., Vilalta-
Franch, J., & Lopez-Pousa, S. (2014). Discrepancies regarding 
the quality of life of patients with alzheimer’s disease: A three-
year longitudinal study. Journal of Alzheimer’s Disease, 39(3), 
511–525.
 3. Australian Institute of Health and Welfare. (2012). Residential 
aged care in Australia 2010–11: A statistical overview. Canberra: 
AIHW.
 4. Harris-Kojetin, L., Sengupta, M., Park-Lee, E., & Valverde, R. 
(2013). Long-term care services in the United States: 2013 over-
view. Hyattsville, MD: National Center for Health Statistics.
 5. Hoffmann, F., Kaduszkiewicz, H., Glaeske, G., van den Bussche, 
H., & Koller, D. (2014). Prevalence of dementia in nursing home 
and community-dwelling older adults in Germany. Aging Clinical 
and Experimental Research, 26(5), 555–559.
 6. Stewart, R., Hotopf, M., Dewey, M., Ballard, C., Bisla, J., Calem, 
M., Fahmy, V., Hockley, J., Kinley, J., Pearce, H., Saraf, A., & 
Begum, A. (2014). Current prevalence of dementia, depression 
and behavioural problems in the older adult care home sector: 
The South East London care home survey. Age and Ageing, 43(4), 
562–567.
 7. Brazier, J., Ratcliffe, J., Salomon, J. A., & Tsuchiya, A. (2007). 
Measuring and valuing health benefits for economic evaluation. 
Oxford: Oxford University Press.
 8. Krabbe, P. F. M., Stouhard, M. E., Essink-Bot, M. L., & Bonsel, G. 
J. (1999). The effect of adding cognitive dimension to the EuroQol 
multiattribute health-status classification system. Journal of Clini-
cal Epidemiology, 52(4), 293–301.
 9. Wolfs, C. A. G., Dirksen, C. D., Kessels, A., Willems, D. C. 
M., Verhey, F. R. J., & Severens, J. L. (2007). Performance of 
the EQ-5D and the EQ-5D+C in elderly patients with cognitive 
impairments. Health and Quality of Life Outcomes, 5(33), 1–10.
 10. Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). 
Comparing the standard EQ-5D three-level system with a five-
level version. Value in Health, 11(2), 275–284.
 11. Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, 
D., Bonsel, G., & Badia, X. (2011). Development and preliminary 
testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual-
ity of Life Research, 20(10), 1727–1736.
 12. Aguirre, E., Kang, S., Hoare, Z., Edwards, R. T., & Orrell, M. 
(2016). How does the EQ-5D perform when measuring quality 
of life in dementia against two other dementia-specific outcome 
measures? Quality of Life Research, 25(1), 45–49.
 Quality of Life Research
1 3
 13. Orgeta, V., Edwards, R. T., Hounsome, B., Orrell, M., & Woods, 
B. (2015). The use of the EQ-5D as a measure of health-related 
quality of life in people with dementia and their carers. Quality 
of Life Research, 24(2), 315–324.
 14. Shearer, J., Green, C., Ritchie, C., & Zajicek, J. (2012). Health 
state values for use in the economic evaluation of treatments for 
Alzheimer’s disease. Drugs and Aging, 29(1), 31–43.
 15. Bryan, S., Hardyman, W., Bentham, P., Buckley, A., & Laight, A. 
(2005). Proxy completion of EQ-5D in patients with dementia. 
Quality of Life Research, 14(1), 107–118.
 16. Diaz-Redondo, A., Rodriguez-Blazquez, C., Ayala, A., Martinez-
Martin, P., Forjaz, M. J., Spanish Research Group on Quality of 
Life and Aging (2014). EQ-5D rated by proxy in institutionalized 
older adults with dementia: Psychometric pros and cons. Geriat-
rics and Gerontology International, 14(2), 346–353.
 17. Smith, S., Lamping, D. L., Banerjee, S., Harwood, R. H., Foley, 
B., Smith, P., Cook, J. C., Murray, J., Prince, M., Levin, E., Mann, 
A., & Knapp, M. (2007). Development of a new measure of 
health-related quality of life for people with dementia: DEMQOL. 
Psychological Medicine, 37(5), 737–746.
 18. Smith, S., Lamping, D., Banerjee, S., Harwood, R., & Foley, B. 
(2005). Measurement of health-related quality of life for people 
with dementia: development of a new instrument (DEMQOL) and 
an evaluation of current methodology. Health Technology Assess-
ment, 9(10), 1–112.
 19. Mulhern, B., Rowen, D., Brazier, J., Smith, S., Romeo, R., Tait, 
R., Watchurst, C., Chua, K.-C., Loftus, V., Young, T., Lamping, 
D., Knapp, M., Howard, R., & Banerjee, S. (2013). Development 
of DEMQOL-U and DEMQOL-PROXY-U: Generation of pref-
erence-based indices from DEMQOL and DEMQOL-PROXY for 
use in economic evaluation. Health Technology Assessment, 17(5), 
1–160.
 20. Rowen, D., Mulhern, B., Banerjee, S., Hout, B., Young, T. A., 
Knapp, M., Smith, S. C., Lamping, D. L., & Brazier, J. E. (2012). 
Estimating preference-based single Index measures for dementia 
using DEMQOL and DEMQOL-Proxy. Value in Health, 15(2), 
346–356.
 21. Jorm, A. F., Mackinnon, A. J., Henderson, A. S., Scott, R., Chris-
tensen, H., Korten, A. E., Cullen, J. S., & Mulligan, R. (1995). 
The Psychogeriatric Assessment Scales: A multi-dimensional 
alternative to the categorical diagnoses of dementia and depres-
sion in the elderly. Psychological Medicine, 25(3), 447–460.
 22. Hounsome, N., Orrell, M., & Edwards, R. T. (2011). EQ-5D as a 
quality of life measure in people with dementia and their carers: 
Evidence and key issues. Value in Health, 14(2), 390–399.
 23. Devlin, N., Shah, K., Feng, Y., Mulhern, B., & van Hout, B. 
(2016). Valuing health-related quality of life: An EQ-5D-5L 
value set for England. Health Economics and Decision Science, 
School of Health and Related Research (ScHARR), University of 
Sheffield.
 24. Shah, S., Vanclay, F., & Cooper, B. (1989). Improving the sen-
sitivity of the Barthel Index for stroke rehabilitation. Journal of 
Clinical Epidemiology, 42(8), 703–709.
 25. Kaufer, D. I., Cummings, J. L., Ketchel, P., Smith, V., MacMillan, 
A., Shelley, T., Lopez, O. L., & DeKosky, S. T. (2000). Validation 
of the NPI-Q, a brief clinical form of the neuropsychiatric inven-
tory. Journal of Neuropsychiatry and Clinical Neurosciences, 
12(2), 233–239.
 26. Hinkle, D., Wiersma, W., & Jurs, S. (2003). Applied statistics for 
the behavioral sciences (5th edn.). Boston: Houghton Mifflin.
 27. Bland, J. M., & Altman, D. G. (1986). Statistical methods for 
assessing agreement between two methods of clinical measure-
ment. The Lancet, 1(8476), 307–310.
 28. Cohen, J. (1969). Statistical power analysis for the behavioral 
sciences. New York, NY: Academic Press.
 29. Naglie, G., Hogan, D. B., Krahn, M., Beattie, B. L., Black, S. E., 
Macknight, C., Freedman, M., Patterson, C., Borrie, M., Bergman, 
H., Byszewski, A., Streiner, D., Irvine, J., Ritvo, P., Comrie, J., 
Kowgier, M., & Tomlinson, G. (2011). Predictors of patient self-
ratings of quality of life in Alzheimer disease: Cross-sectional 
results from the Canadian Alzheimer’s Disease Quality of Life 
Study. The American Journal of Geriatric Psychiatry, 19(10), 
881–890.
 30. Drummond, M., & McGuire, A. (2001). Economic evaluation in 
health care: Merging theory with practice. Oxford: Oxford Uni-
versity Press.
 31. Kunz, S. (2010). Psychometric properties of the EQ-5D in a 
study of people with mild to moderate dementia. Quality of Life 
Research, 19(3), 425–434.
 32. Banerjee, S., Smith, S. C., Lamping, D. L., Harwood, R. H., 
Foley, B., Smith, P., Murray, J., Prince, M., Levin, E., Mann, 
A., & Knapp, M. (2006). Quality of life in dementia: more than 
just cognition. An analysis of associations with quality of life in 
dementia. Journal of Neurology, Neurosurgery and Psychiatry, 
77(2), 146–148.
 33. Woods, B., Thorgrimsen, L., Spector, A., Royan, L., & Orrell, M. 
(2006). Improved quality of life and cognitive stimulation therapy 
in dementia. Aging and Mental Health, 10(3), 219–226.
 34. Castro-Monteiro, E., Forjaz, M. J., Ayala, A., Rodriguez-
Blazquez, C., Fernandez-Mayoralas, G., Diaz-Redondo, A., & 
Martinez-Martin, P. (2014). Change and predictors of quality of 
life in institutionalized older adults with dementia. Quality of Life 
Research, 23(9), 2595–2601.
 35. Goldfeld, K. S., Hamel, M. B., & Mitchell, S. L. (2012). Mapping 
health status measures to a utility measure in a study of nursing 
home residents with advanced dementia. Medical Care, 50(5), 
446–451.
 36. Sheehan, B. D., Lall, R., Stinton, C., Mitchell, K., Gage, H., Hol-
land, C., & Katz, J. (2012). Patient and proxy measurement of 
quality of life among general hospital in-patients with dementia. 
Aging and Mental Health, 16(5), 603–607.
 37. Arons, A. M., Krabbe, P. F., Scholzel-Dorenbos, C. J., van der 
Wilt, G. J., & Rikkert, M. G. (2013). Quality of life in dementia: 
A study on proxy bias. BMC Medical Research Methodology, 13, 
110.
 38. Arons, A. M., Krabbe, P. F., Scholzel-Dorenbos, C. J., van der 
Wilt, G. J., & Rikkert, M. G. (2012). Thurstone scaling revealed 
systematic health-state valuation differences between patients with 
dementia and proxies. Journal of Clinical Epidemiology, 65(8), 
897–905.
 39. Gomez-Gallego, M., Gomez-Garcia, J., & Ato-Lozano, E. (2015). 
Addressing the bias problem in the assessment of the quality of 
life of patients with dementia: Determinants of the accuracy and 
precision of the proxy ratings. The Journal of Nutrition, Health 
and Aging, 19(3), 365–372.
 40. Oremus, M., Tarride, J.-E., Clayton, N., Willingness-to-Pay, C., 
Study, G., & Raina, P. (2014). Health utility scores in Alzhei-
mer’s disease: Differences based on calculation with American 
and Canadian preference weights. Value in Health, 17(1), 77–83.
 41. Olsen, J. A., Lamu, A. N., & Cairns, J. (2017) In search of a 
common currency: A comparison of seven EQ-5D-5L value sets. 
Health Economics. https://doi.org/10.1002/hec.3606.
 42. Devlin, N., Shah, K., Feng, Y., Mulhern, B., & van Hout, B. 
(2017). Valuing health-related quality of life: An EQ-5D-5L 
value set for England. Health Economics. http://doi.org/10.1002/
hec.3564.
